Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.

Ksenia Blinova | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Ksenia Blinova | Pharmacology | Best Researcher Award

Associate Director at US Food and Drug Administration, United States

Dr. Ksenia Blinova, Ph.D., is the Associate Director for the Division of Applied Regulatory Science at the U.S. Food and Drug Administration, where she leads innovative research, regulatory reviews, and scientific consultations that advance translational science in support of public health. With a strong academic foundation in physics, mathematics, and cardiac electrophysiology, she has built a distinguished career focused on bridging fundamental science with regulatory applications. Since joining the FDA as a Commissioner’s Fellow, Dr. Blinova has held key leadership roles, including Deputy Director of the Division of Biomedical Physics, where she led multidisciplinary teams in developing over forty regulatory science tools that improved the evaluation of medical devices across fields such as cardiology, neurostimulation, diagnostics, and patient monitoring. Her career reflects a unique combination of scientific excellence, leadership, and commitment to advancing safe and effective medical products, making her an influential figure in the field of regulatory science.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Dr. Ksenia Blinova earned her undergraduate and doctoral degrees in Physics and Mathematics from Moscow State University, where she developed a strong foundation in quantitative sciences and analytical problem-solving. She further advanced her academic journey through a postdoctoral fellowship at the National Heart, Lung, and Blood Institute at the National Institutes of Health. Her research during this period centered on cardiac electrophysiology and metabolism, areas that deepened her expertise in biomedical applications of physical sciences. This educational trajectory not only equipped her with advanced technical knowledge but also gave her a unique interdisciplinary perspective that integrates rigorous physics and mathematical methodologies with life sciences and clinical research. Her educational background has been pivotal in shaping her ability to address complex regulatory and scientific challenges, contributing to her capacity for innovation and leadership in translational science and regulatory policy at the intersection of medicine, technology, and public health.

Experience

Dr. Blinova has built a distinguished career at the U.S. Food and Drug Administration, beginning as a Commissioner’s Fellow and progressing to influential leadership roles. As Deputy Director of the Division of Biomedical Physics in the Center for Devices and Radiological Health, she guided a multidisciplinary team in creating innovative regulatory science tools that addressed critical challenges in medical device safety and effectiveness. Her leadership was instrumental in developing methods and resources for fields such as cardiology, neurostimulation, ophthalmology, in-vivo diagnostics, and advanced patient monitoring. Currently serving as Associate Director for the Division of Applied Regulatory Science in the Office of Clinical Pharmacology, she oversees research, scientific consultations, and regulatory reviews that support the FDA’s translational science priorities. Through these roles, she has combined her technical expertise with strategic vision, ensuring that scientific advancements translate into practical regulatory applications that safeguard patient health and promote medical innovation.

Research Focus

Dr. Blinova’s research focuses on advancing translational and regulatory science to accelerate the safe and effective delivery of medical products to patients. Her early work in cardiac electrophysiology and metabolism provided insights into fundamental mechanisms of heart function, laying the groundwork for her later contributions in biomedical physics and device evaluation. At the FDA, she has led research efforts that integrate computational modeling, experimental studies, and regulatory tool development to address complex safety and efficacy challenges in medical devices and drug-device combinations. Her team has developed innovative approaches to evaluate technologies in cardiology, neurostimulation, electrical safety, diagnostics, and patient monitoring, ensuring that regulatory science keeps pace with rapid technological advances. By bridging basic science, applied research, and policy, her work exemplifies the role of regulatory science in translating innovation into tangible benefits for patients and healthcare systems, while maintaining a focus on safety, effectiveness, and public health impact.

Award and Honor

Throughout her career, Dr. Blinova has been recognized for her leadership, innovation, and contributions to regulatory science. Her accomplishments include guiding the development of over forty regulatory tools that have had a lasting impact on how medical devices are assessed for safety and effectiveness. These achievements reflect not only her scientific expertise but also her ability to collaborate across disciplines to solve pressing healthcare challenges. Her recognition within the FDA and broader scientific community underscores her role as a leader who consistently advances the field of translational science. Honors and awards in her career highlight her success in bridging science and regulation, her dedication to patient safety, and her influence in shaping modern approaches to medical product evaluation. These distinctions serve as a testament to her sustained contributions, her commitment to innovation, and her growing impact as a respected figure in regulatory and biomedical research.

Publication Top Notes

  • Title: Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
    Authors: M. Iveth Garcia, Bhavya Bhardwaj, Keri Dame, Verena Charwat, Brian A. Siemons, Ishan Goswami, Omnia A. Ismaiel, Sabyasachy Mistry, Tromondae K. Feaster, Kevin E. Healy, et al.
    Year: 2025

  • Title: In Vitro Assay Development to Study Pulse Field Ablation Outcome Using Solanum Tuberosum
    Authors: Akshay Narkar, Abouzar Kaboudian, Yasaman Ardeshirpour, Maura Casciola, Tromondae Feaster, Ksenia Blinova
    Year: 2024
    Citations: 2

  • Title: Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues
    Authors: Tromondae K. Feaster, Jourdan K. Ewoldt, Anna Avila, Maura Casciola, Akshay Narkar, Christopher S. Chen, Ksenia Blinova
    Year: 2024

  • Title: Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells
    Authors: Ksenia Blinova, J. Pierson, A. Narkar
    Year: 2023

  • Title: Human in vitro assay for irreversible electroporation cardiac ablation
    Authors: Maura Casciola, Tromondae K. Feaster, M. J. Caiola, D. Keck, Ksenia Blinova
    Year: 2023

  • Title: Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
    Authors: Tromondae K. Feaster, N. Feric, I. Pallotta, A. Narkar, M. Casciola, M. P. Graziano, R. Aschar-Sobbi, Ksenia Blinova
    Year: 2022

  • Title: Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2022

  • Title: Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
    Authors: Akshay Narkar, Tromondae K. Feaster, Maura Casciola, Ksenia Blinova
    Year: 2022

  • Title: Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
    Authors: Maura Casciola, Devin Keck, Tromondae K. Feaster, Ksenia Blinova
    Year: 2022

  • Title: Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
    Authors: Akshay Narkar, James M. Willard, Ksenia Blinova
    Year: 2022

  • Title: Cardiovascular medical devices: Regulatory science research overview in the office of science and engineering laboratories (OSEL) at the food and drug administration (FDA)
    Authors: K. Aycock, Ksenia Blinova, M. Casciola, B. Craven, M. Di Prima, G. D’Souza, N. Duraiswamy, M. Farahmand, P. Hariharan, L. Herbertson, et al.
    Year: 2021

  • Title: Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
    Authors: Tromondae K. Feaster, Maura Casciola, Akshay Narkar, Ksenia Blinova
    Year: 2021

Conclusion

Dr. Ksenia Blinova has demonstrated exceptional expertise and leadership in translational and regulatory science, particularly in the evaluation and development of cardiac therapies and medical devices. Her extensive body of research, including numerous high-impact publications on human in vitro cardiac models, contractility modulation, and electroporation assays, reflects a consistent focus on innovative approaches that bridge fundamental science with practical clinical and regulatory applications. She has led multidisciplinary teams to develop tools and methodologies that enhance patient safety, accelerate medical innovation, and provide reliable scientific evidence for regulatory decisions. Her work not only advances the understanding of cardiac electrophysiology and device performance but also sets new standards for predictive, nonclinical cardiac research. Overall, Dr. Blinova’s contributions exemplify the qualities of a pioneering researcher whose scientific rigor, leadership, and commitment to public health make her highly deserving of recognition in any Best Researcher Award.

Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Professora Associada at Universidade Federal do Pará, Brazil

Dr. Marta Chagas Monteiro is a distinguished biomedical researcher specializing in microbiology, immunology, and pharmacology. She holds a CNPq 1D Productivity Scholarship and serves as a professor and research coordinator at the Federal University of Pará (UFPA), Brazil. With over two decades of experience, she has made significant contributions to understanding infectious diseases, immune responses, and drug development. Her collaborations span international institutions, including the University of São Paulo, Aston University, and the University of Shanghai. As a prolific researcher, she has authored over 100 high-impact publications and serves on the editorial boards of leading scientific journals. Dr. Monteiro is also an active mentor, shaping future scientists through postgraduate programs. Her expertise in oxidative stress, biomarkers, and xenobiotic toxicity has positioned her as a leading figure in biomedical research, earning her recognition from national and international funding agencies.

Professional Profile

Education

Dr. Monteiro earned her Ph.D. in Basic and Applied Immunology from the University of São Paulo in 2004, focusing on immune responses and cellular migration in infectious diseases. Prior to that, she completed her Master’s degree in the same field at USP in 2000, with research centered on parasitology and pharmacology. Her academic foundation was laid at the Federal University of Pará, where she obtained a bachelor’s degree in Medical Biology in 1997. Over the years, she has pursued numerous specialized training courses in pharmacology, immunology, and biomedicine, including programs on oxidative stress, epigenetics, and experimental pharmacology. Her continuous education reflects a commitment to interdisciplinary research, integrating immunopharmacology, microbiology, and biotechnology into her work. This extensive academic background has enabled her to make significant contributions to scientific advancements, particularly in the study of immune responses, biomarkers, and the pharmacological effects of drugs on infectious and neurodegenerative diseases.

Professional Experience

Dr. Monteiro is a professor and coordinator at the Faculty of Pharmacy at UFPA, where she leads the Laboratory of Oxidative Stress and Clinical Immunology. She is actively involved in postgraduate programs in pharmaceutical sciences, neuroscience, and pharmacology. Beyond academia, she serves as an expert evaluator for major funding organizations, including CNPq, SUS, and INEP. Her work also extends to international collaborations, with ongoing projects in partnership with institutions in Brazil, the UK, and China. Additionally, she is a consultant for over 15 research development agencies and a reviewer for more than 90 scientific journals. As part of her professional engagements, she has contributed to the development of new pharmacological treatments, diagnostic tools, and innovative technologies in immunology. Her leadership in academia and research has significantly impacted biomedical advancements, particularly in the areas of infectious disease management and pharmacological interventions.

Research Interests

Dr. Monteiro’s research focuses on microbiology, clinical immunology, and pharmacology, with a particular emphasis on biomarkers and immune responses in infectious diseases. She investigates the pharmacological activities of drugs and natural products, as well as their toxicological effects on human health. Her work extends to studying oxidative stress, inflammation, and xenobiotic-mediated toxicity, providing insights into the development of new therapeutic strategies. Additionally, she explores neurodegenerative, autoimmune, and parasitic diseases, including malaria, tuberculosis, leishmaniasis, and sepsis. Through her extensive research, she has contributed to advancements in immunopharmacology, helping to identify novel drug targets and therapeutic interventions. Her multidisciplinary approach, combining molecular biology, pharmacology, and biotechnology, has led to breakthroughs in disease diagnostics and treatment methodologies, further solidifying her reputation as a leading expert in biomedical sciences.

Awards and Honors

Dr. Monteiro has received numerous accolades in recognition of her contributions to biomedical research. She is a recipient of the prestigious CNPq 1D Productivity Scholarship, which highlights her excellence in scientific investigation. Her research has been funded by national and international agencies, reflecting the high impact of her work. She has also been recognized for her role as an editor and reviewer for top-tier journals, including Frontiers in Immunology and Oxidative Medicine and Cellular Longevity. Additionally, she has contributed to the scientific community as a consultant and evaluator for research projects funded by leading organizations. Her patents and published innovations in immunopharmacology and microbiology have further established her as a respected figure in the field. Through her dedication to research, teaching, and mentorship, she has made a lasting impact on the scientific landscape, earning widespread recognition for her contributions to global health and biomedical advancements.

Conclusion

Dr. Marta Chagas Monteiro is highly qualified for the Best Researcher Award due to her extensive contributions, leadership in microbiology and immunology, international collaborations, and significant research impact. Strengthening her translational research and public engagement could further enhance her profile, but overall, she is a strong candidate.

Publications Top Notes

  1. Monteiro, M.C., Quadros Gomes, B.A., Dos Santos, S.M., Gato, L.D.S., Coleman, M.D. (2025)

    • Alpha-Lipoic Acid Reduces Neuroinflammation and Oxidative Stress Induced by Dapsone in an Animal Model.

    • Journal: Nutrients

    • Citations: 0

  2. Monteiro, M.C., de Farias, E.C.F., Pavão Júnior, M.J.C., de Sales, S.C.D., Terreri, M.T.R.A. (2024)

    • Factors associated with mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a resource-poor setting.

    • Journal: Scientific Reports

    • Citations: 2

  3. Monteiro, M.C. (co-author), Dos Santos, É.R.Q., Pantoja, L.V.P.D.S., Farias, S.V., Maia, J.G.S., Maia, C.S. (2024)

    • Linalool-rich rosewood essential oil (Aniba rosaeodora Ducke) mitigates emotional and neurochemical impairments induced by ethanol binge-like exposure during adolescence in female rats.

    • Journal: Biomedicine and Pharmacotherapy

    • Citations: 0

  4. Monteiro, M.C., Navegantes-Lima, K.C., Gaspar, S.L.D.F., De, A.L., Sovrani, V. (2024)

    • Lipid Fraction from Agaricus brasiliensis as a Potential Therapeutic Agent for Lethal Sepsis in Mice.

    • Journal: Antioxidants

    • Citations: 0

  5. Monteiro, M.C. (co-author), de Farias, E.C.F., Nascimento, L.M.P.P., Pavão Júnior, M.J.C., Clemente, G., Terreri, M.T.R.A. (2024)

    • Plasma IL-17A is increased in patients with critical MIS-C and associated with in-hospital mortality.

    • Journal: Frontiers in Immunology

    • Citations: 0

  6. Monteiro, M.C., Matos-Sousa, J.M., Chemelo, V.S., Frazão, D.R., Lima, R.R. (2024)

    • Is there any association between the presence of biomarkers and apical periodontitis? A systematic review.

    • Journal: [No source information available]

    • Citations: 3

  7. Monteiro, M.C., Valois, F.P., Bezerra, K.C.A., da Costa Assunção, F.P., Machado, N.T. (2024)

    • Improving the Antioxidant Activity, Yield, and Hydrocarbon Content of Bio-Oil from the Pyrolysis of Açaí Seeds by Chemical Activation: Effect of Temperature and Molarity.

    • Journal: Catalysts

    • Citations: 1

  8. Monteiro, M.C., Meneses, C.C.F., de Sousa, P.R.M., Lima, K.C.N., Lameira, J. (2023)

    • Caffeic Acid-Zinc Basic Salt/Chitosan Nanohybrid Possesses Controlled Release Properties and Exhibits In Vivo Anti-Inflammatory Activities.

    • Journal: Molecules

    • Citations: 3

  9. Monteiro, M.C. (co-author), Camara, F.M.S., da Conceição, B.C., Cardoso, E.K.S., Maia, C.S., Fontes-Júnior, E.A. (2023)

    • Margaritaria nobilis L.f. (Phyllanthaceae) Ethanolic Extract: Low Acute Oral Toxicity and Antinociceptive Activity.

    • Journal: Pharmaceuticals

    • Citations: 1

  10. Monteiro, M.C. (co-author), Dorneles, G.P., Teixeira, P.C., Peres, A.L., Wendland, E.M., Romão, P.R.T. (2023)

  • Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients.

  • Journal: Journal of Molecular Medicine

  • Citations: 8

 

Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

full professor at Pázmány Péter Catholic University, Hungary

Franciska Vidáné Dr. Erdő is a distinguished researcher and professor in drug research and development, with extensive experience in academia and the pharmaceutical industry. Born on May 28, 1964, in Budapest, Hungary, she has contributed significantly to pharmacology, drug delivery, and biomedical research. Over her career, she has held leadership roles in prestigious institutions across Hungary, Germany, and France. As a full professor and lab head at Pázmány Péter Catholic University, she plays a key role in advancing scientific knowledge. Her research has been widely recognized, earning her multiple fellowships and memberships in international scientific societies. Dr. Erdő has supervised numerous students, organized international scientific meetings, and served as a reviewer for high-impact journals. She is also actively involved in grant evaluation for major research funding agencies in Europe, further establishing her as a leading expert in her field.

Professional Profile

Education

Dr. Erdő’s academic journey is rooted in pharmaceutical sciences. She obtained her MSc in Pharmacy from Semmelweis University, Faculty of Pharmacy, in 1987 with excellent distinction. She continued her studies at the same institution, earning her University Doctor title in pharmacology in 1994, followed by a PhD in 1997, both summa cum laude. To further enhance her expertise, she pursued a habilitation at Pázmány Péter Catholic University in 2019, ultimately achieving the title of full professor in 2024. Additionally, she has undertaken specialized training, including EU grant writing and experimental animal research under new EU regulations. Her diverse educational background has enabled her to excel in drug development, pharmacology, and biotechnology, equipping her with a strong foundation to lead innovative research in these fields.

Professional Experience

Dr. Erdő’s professional career spans more than three decades, encompassing roles in academia, research institutes, and the pharmaceutical industry. She has held various research fellow and senior research fellow positions in leading institutions such as Sanofi-Synthelabo Chinoin, IVAX Drug Research Institute, and SOLVO Biotechnology. Between 2000 and 2003, she was a Max Planck Fellow at the Max-Planck Institute in Germany, furthering her expertise in neurological research. She has also worked as a scientific researcher at Charité Medical University in Berlin. Since 2014, she has been an integral part of Pázmány Péter Catholic University, where she has progressed from senior research fellow to full professor and lab head. Her leadership in drug research and development, coupled with her extensive collaborations with international institutions, has significantly contributed to the advancement of pharmaceutical sciences.

Research Interests

Dr. Erdő’s research focuses on drug delivery across physiological barriers, including the skin, blood-brain barrier, and mucosal tissues. Her studies explore transdermal and intranasal drug administration, pharmacokinetics, and tissue engineering. She has contributed to the development of lab-on-a-chip models for drug testing, providing innovative solutions for pharmaceutical research. Her interdisciplinary approach combines pharmacology, biomedical engineering, and nanotechnology to improve drug formulation and delivery methods. She has authored numerous high-impact publications on skin permeability, microfluidic diffusion chambers, and age-related changes in drug absorption. Her research also includes in vitro and ex vivo studies on skin-on-a-chip platforms, contributing to advancements in personalized medicine. Dr. Erdő’s work has gained international recognition, shaping the future of drug development and targeted therapy solutions.

Awards and Honors

Dr. Erdő has been the recipient of numerous prestigious awards and fellowships throughout her career. She was a Max Planck Fellow from 2000 to 2003, a Charité Medical University Scholar in 2006, and a recipient of the LE STUDIUM Fellowship in 2022 under the Smart Loire Valley program in France. Her excellence in teaching and research has been recognized through multiple Teaching-Research Excellence Scholarships at Pázmány Péter Catholic University. She has also received publication fellowships for her outstanding contributions to scientific literature. Additionally, she plays a crucial role as a grant evaluator for the EU’s Horizon programs, the Austrian Science Fund, and other major research funding agencies. Her achievements highlight her significant impact on the global scientific community, reinforcing her reputation as a leading expert in pharmaceutical and biomedical research.

Conclusion

Dr. Franciska Vidáné Erdő is a highly suitable candidate for the Best Researcher Award due to her outstanding contributions to drug research, mentorship, and international collaborations. Her extensive publication record, leadership in scientific organizations, and impact on pharmacology and biomedical sciences make her a strong contender. Enhancing industry engagement and public science communication could further solidify her position as a top researcher.

Publications Top Noted

1. In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering

  • Author: Erdő F., et al.
  • Year: 2025
  • Journal: Bioengineering
  • DOI: 10.3390/bioengineering12030230

2. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

3. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

4. Mathematical Modeling of Transdermal Delivery of Topical Drug Formulations in a Dynamic Microfluidic Diffusion Chamber in Health and Disease

5. Rodent Models of Dermatological Disorders

6. Models for Barrier Understanding in Health and Disease in Lab-on-a-Chips

7. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

8. Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing

9. Editorial: Women in Drug Metabolism and Transport: 2021

10. Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers

11. Novel Aspects of Raman Spectroscopy in Skin Research

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Experimental Dermatology
  • DOI: 10.1111/exd.14645

12. Characterization and Ex Vivo Evaluation of Excised Skin Samples as Substitutes for Human Dermal Barrier in Pharmaceutical and Dermatological Studies

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Skin Research and Technology
  • DOI: 10.1111/srt.13165

13. Drug Delivery through the Psoriatic Epidermal Barrier—A “Skin-On-A-Chip” Permeability Study and Ex Vivo Optical Imaging

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms23084237

14. Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

15. Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents

 

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at University of Asia Pacific, Bangladesh

Dr. Shihab Uddin Ahmad (RPh, PhD) is an accomplished academic and researcher specializing in pharmacology, drug discovery, and molecular biology. Currently serving as an Assistant Professor and Coordinator of the Master of Pharmacy in Clinical Pharmacy and Pharmacology Program at the University of Asia Pacific, Bangladesh, he has made significant contributions to natural product pharmacology and functional medicine. With a postdoctoral background from Shanghai Jiao Tong University, he has actively engaged in cutting-edge research, particularly in stem cell therapy, metabolic diseases, and pharmaceutical innovations. His expertise spans experimental pharmacology, biotechnology, and advanced drug delivery systems, with a strong emphasis on translational research. A prolific author and patent holder, Dr. Ahmad’s work has been recognized through numerous publications in high-impact journals. His dedication to academic excellence and research innovation positions him as a leader in the field of pharmaceutical sciences.

Professional Profile

Education

Dr. Ahmad holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Universiti Kebangsaan Malaysia, where he focused on wound healing properties of medicinal plants. He earned his Master of Science in Pharmaceutical Technology (M. Pharm. Tech.) and Bachelor of Pharmacy (B. Pharm.) from the University of Asia Pacific, Bangladesh, demonstrating an early interest in drug formulation, bioactive compounds, and molecular pharmacology. His academic journey has been driven by a passion for pharmacological research and drug discovery, equipping him with extensive biomedical expertise. Through his education, he developed proficiency in biochemical and molecular techniques, tissue recombination assays, and computational drug analysis. His multidisciplinary training in pharmacology, biotechnology, and clinical pharmacy has enabled him to bridge the gap between traditional medicine and modern pharmaceutical innovations, fostering impactful research in phytomedicine and metabolic disorders.

Professional Experience

Dr. Ahmad has a diverse professional background, spanning academia, industry, and postdoctoral research. Currently, he serves as the Coordinator and Assistant Professor at the University of Asia Pacific, Bangladesh, where he oversees research and academic programs in clinical pharmacy and pharmacology. Previously, he was a Postdoctoral Fellow at Renji Hospital, Shanghai Jiao Tong University, China, where he worked on cancer research and stem cell-based therapies. His industry experience includes serving as a Scientific Program Coordinator and Senior Executive at Ibn-Sina Natural Medicine Division, focusing on herbal drug development and product management. Additionally, he worked in the pharmaceutical production sector, gaining hands-on expertise in drug formulation, quality control, and regulatory affairs. His combined experience in research, industry, and education makes him a well-rounded professional with a strong impact in the field of drug discovery and molecular pharmacology.

Research Interests

Dr. Ahmad’s research interests focus on natural product pharmacology, drug delivery technology, and molecular biology, particularly in the development of phytomedicines and nutraceuticals. His work explores metabolic disorders, including obesity, diabetes, fatty liver disease, and postmenopausal hormonal imbalances such as PCOS and osteoporosis. He has also contributed to cancer pharmacology, investigating novel anticancer compounds and nanoparticle-based drug delivery systems. His expertise extends to neurodegenerative diseases and tissue regeneration, utilizing CRISPR technology, stem cell research, and bioinformatics to advance therapeutic innovations. By integrating experimental pharmacology with computational analysis, he aims to bridge the gap between traditional medicine and modern drug development. His ongoing research projects involve nanomedicine, polymeric drug delivery, and personalized medicine, reflecting a multidisciplinary approach to pharmaceutical sciences.

Awards and Honors

Dr. Ahmad has received numerous awards and recognitions for his contributions to pharmaceutical sciences and biomedical research. He is a patent holder for an innovative wound healing medicament, showcasing his ability to translate research into real-world applications. His research projects have been supported by prestigious grants from institutions such as UAP, Dhaka University, and international funding agencies. He has been an invited speaker at scientific conferences and has received accolades for his publications in high-impact journals. His work in drug discovery and therapeutic innovations has positioned him as a leading researcher in phytomedicine and clinical pharmacology. With an impressive track record of scientific achievements, mentorship, and academic leadership, Dr. Ahmad continues to make significant contributions to the advancement of pharmaceutical and biomedical sciences.

Conclusion

Dr. Shihab Uddin Ahmad is a strong candidate for the Best Researcher Award due to his extensive research contributions, leadership, and innovation in pharmacology and drug discovery. His combination of academic excellence, technical expertise, and mentorship makes him well-deserving of recognition. While enhancing international collaboration and increasing high-impact publications would further strengthen his profile, his overall achievements position him as a highly competitive contender for the award.

Publications Top Noted

  • Network Pharmacology, Molecular Docking and Experimental Validation on Potential Application of Diabetic Wound Healing of Cinnamomum zeylanicum Through Matrix Metalloproteinases-8 And 9 (MMP-8 And MMP-9)

    • Authors: Akter, S., Ahmad, S., Bhuiyan, M., Dewan, I., Reza, R., Morshed, N., Samdani, M., Reza, M., Kumer, A., Mohamed, I. N.
    • Year: 2025
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/DDDT.S489113

  • Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design

    • Authors: Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M., Rahman, F. I., Mohamed, I. N., Reza, M. S.
    • Year: 2023
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/dddt.s432790

  • Antidiabetic Effect of Actinodaphne angustifolia and Profiling of Bioactive Metabolites using UPLC-QToF/ESI-MS Method

  • Improvement of lipid profile and hepatic oxidative stress in high-fat-diet-induced hyperlipidemic Swiss albino rats by Piper betle juice: evidences from in vivo and in silico studies

    • Authors: Jing, X., Sarker, M. R., Gifari, A. J., Maruf, R. A., Alam, S., Khan, F., Soma, M. A., Hossain, S., Ming, L. C., Ahmad, S. U.
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.1

  • A Dose Optimization Study of Marantodes pumilum (Blume) Kuntze Extracts for Wound Healing Effect in Animal Model

  • Evaluation of Wound-Healing and Antioxidant Effects of Marantodes pumilum (Blume) Kuntze in an Excision Wound Model

  • The Pharmacological Potential of Oil Palm Phenolics (OPP) Individual Components

    • Author: Ahmad, S. U.
    • Year: 2019
    • Journal: International Journal of Medical Sciences
    • DOI: 10.7150/ijms.29934

  • Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction

  • Antioxidant and Anti-inflammatory Activities of Marantodes pumilum (Blume) Kuntze and Their Relationship with the Phytochemical Content

  • Labisia pumila improves wound healing process in ovariectomized rat model

  • Phyto-estrogenic effects of Marantodes pumilum (Blume) kuntze syn. Labisia pumila (Blume) Fern.-Vill. for the prevention and treatment of post-menopausal diseases

    • Authors: Ahmad, S. U., Azam, A., Shuid, A. N., Mohamed, I. N.
    • Year: 2017
    • Journal: Indian Journal of Traditional Knowledge
    • EID: 2-s2.0-85011866753

 

Shanika Karunanayaka | Pharmaceutical Sciences | Best Researcher Award

Published on by World Top Scientists

Mrs. Shanika Karunanayaka | Pharmaceutical Sciences | Best Researcher Award

Senior Lecturer, University of Ruhuna, Sri Lanka

Shanika Vindyani Karunanayaka is a dedicated Senior Lecturer in the Department of Pharmacy at the Faculty of Allied Health Sciences, University of Ruhuna, Sri Lanka. With a passion for education and research, she has significantly contributed to the field of pharmaceutical sciences since 2013. Shanika holds a Master of Philosophy in Pharmaceutical Sciences, where she explored innovative formulations for hand sanitizers, and she continues to inspire the next generation of pharmacists through her engaging teaching and mentorship. 📚✨

Publication Profile

Google scholar

Education

Shanika completed her Master of Philosophy in Pharmaceutical Sciences at the Medical Research Institute in Colombo, Sri Lanka, and the University of Ruhuna, where her thesis focused on the formulation and evaluation of alcohol-based and non-alcohol-based hand rubs using Aloe vera and essential oils. She earned her Bachelor of Pharmacy degree from the University of Peradeniya, achieving a remarkable GPA of 3.54/4.0, demonstrating her academic excellence. 🎓🌱

Experience

With a strong background in pharmacy education, Shanika has held various positions at the University of Ruhuna, including Senior Lecturer, Lecturer, and Temporary Lecturer. Her roles have involved lecturing, conducting laboratory sessions, supervising undergraduate research projects, and engaging in administrative tasks, all while actively participating in research and curriculum development. 💼🔬

Research Focus

Shanika’s research primarily focuses on pharmaceutics, pharmaceutical microbiology, and formulation development, emphasizing patenting and commercialization. She is particularly interested in developing innovative hand sanitizers and exploring their antimicrobial efficacy against various pathogens. Her work aims to bridge the gap between academia and industry, contributing to public health initiatives. 🧪💡

Awards and Honors

Throughout her career, Shanika has received recognition for her contributions to pharmaceutical education and research, although specific awards and honors were not detailed in her profile. Her dedication to advancing the field and mentoring students exemplifies her commitment to excellence in pharmacy. 🏆🌟

Publication Highlights

Shanika has published several notable articles in prestigious journals, contributing significantly to the field of pharmaceutical sciences. Some of her key publications include:

Government Pharmacists’ Perceptions on Continuing Education (2017) – 15th Open University Research Session.

Evaluation of in vitro and in vivo antimicrobial efficacy of non-alcohol-based herbal hand scrubs (2021) – Asian Journal of Pharmacognosy.

Development of novel chlorhexidine gluconate hand scrub with Aloe vera (2021) – Asian Journal of Pharmacognosy.

Evaluation of the Efficacy of Alcohol-Based Herbal Hand Rubs Against Selected Pathogens (2023) – International Ruhuna University Faculty of Allied Health Sciences Research Symposium.

Analyzing the examination results to measure the effectiveness of online teaching during the COVID-19 pandemic (2024) – The Asia Pacific Scholar-Medical and Health Professional Education.

Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Published on by World Top Scientists

Ms. Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Associate Professor, S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, India

Dr. Baby Rabiya Parveen is a dedicated researcher currently pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. With a Master’s in Pharmaceutical Chemistry and a Bachelor’s in Pharmacy, both from S.D. College of Pharmacy, her academic journey has been marked by excellence and a commitment to advancing pharmaceutical sciences. Her research interests span the synthesis of novel pharmaceutical compounds and their biological evaluations, contributing significantly to her field. 🌟

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Educational Background: Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry and holds both a Master’s and Bachelor’s degree in Pharmaceutical Chemistry with impressive academic performance.
  2. Diverse Workshop Participation: She has actively participated in numerous workshops and faculty development programs covering a wide range of topics relevant to pharmaceutical research, including intellectual property rights, drug regulatory affairs, and biotechnological applications.
  3. Research Contributions: Rabiya has contributed significantly to the field with multiple research papers on topics such as novel oxazine derivatives, antimicrobial agents, and drug synthesis. Her work on molecular docking and synthesis of new compounds demonstrates a strong commitment to advancing pharmaceutical science.
  4. Conference Presentations: She has presented her research at several national and international conferences, showcasing her work to a broader scientific audience and contributing to the dissemination of knowledge in the field.
  5. Industrial Experience: Her industrial training at Deepali Pharmaceuticals adds practical experience to her academic achievements, enhancing her understanding of real-world applications of her research.
  6. Book Chapters: Rabiya has contributed chapters to books on advanced topics like metallic nanoparticles and ghee standards, reflecting her expertise and ability to communicate complex concepts.

Areas for Improvement:

  1. Publication Record: While Rabiya has a commendable list of research papers, increasing the number of high-impact publications in top-tier journals could further strengthen her research profile.
  2. Research Impact: Demonstrating the practical impact of her research on pharmaceutical practice or policy could provide more evidence of her work’s significance.
  3. Collaborative Research: Engaging in collaborative projects with researchers from other institutions or industries might enhance the scope and applicability of her research.
  4. Grants and Funding: Securing research grants and funding could support more extensive studies and increase her visibility in the research community.

Education

Dr. Baby Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. She completed her Master of Pharmacy in Pharmaceutical Chemistry with honors from S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, and her Bachelor of Pharmacy from the same institution. Her academic background also includes a high distinction in both Intermediate and High School studies. 📚

Experience

Dr. Parveen has gained practical experience through a 45-day industrial training at Deepali Pharmaceuticals, Muzaffarnagar, where she applied her theoretical knowledge to real-world pharmaceutical practices. This hands-on experience complements her extensive academic training and research work. 🏭

Research Focus

Dr. Parveen’s research primarily focuses on the synthesis of novel pharmaceutical compounds and their pharmacological activities. Her work includes the development of new oxazine derivatives, Schiff bases, and isoxazole compounds, with a keen interest in their anti-inflammatory, antimicrobial, and anxiolytic activities. Her research contributes to the development of new therapeutic agents. 🔬

Awards and Honours

Dr. Parveen has been recognized for her academic and research achievements through various awards and honors. Her contributions to pharmaceutical sciences have been acknowledged in multiple conferences and workshops, reflecting her commitment to advancing the field. 🏆

Publications

“Synthesis of some new 3-[5-(substituted-phenyl)-[1,3,4]oxadiazole-2-yl]-1-napthalen-2-yl-propan-1-one” – Published in [Journal Name, Year].

“Synthesis and Biological Evaluation of Some New Amide Derivatives of Sulfonamide” – Published in [Journal Name, Year].

“Synthesis and biological evaluation of some new Schiff base 1,2,4-Triazole Derivatives” – Published in [Journal Name, Year].

“A Short Review on Sulfonamides with Antimicrobial Activity” – Published in [Journal Name, Year].

“A Short Review on Synthesis and Pharmacological Activity of Isoxazole” – Published in [Journal Name, Year].

Conclusion:

Baby Rabiya Parveen is a strong candidate for the Research for Best Researcher Award due to her solid educational background, active participation in professional development, significant research contributions, and industrial experience. Her diverse expertise and dedication to advancing pharmaceutical sciences are commendable. Addressing the areas for improvement, particularly in increasing high-impact publications and demonstrating the practical impact of her research, could further solidify her position as a leading researcher in her field.